Trading IBD Stocks

@bridgewater here is the current chart of MELI, it has a nice little handle is it just breaking through.

How to Handle a Pullback to the Buy Point

Nice little nugget today. I summarized below the link.

Growth Stocks Investing: How To Handle A Pullback To The Buy Point | Investor’s Business Daily (investors.com)
About 40% of breakouts come back to the buy point

• How to you tell if you should sell or hold?|
• Your typical normal pullback will usually occur within days, rather than weeks, of the initial breakout. You should see a gradual price decline with weaker volume as the stock returns to or just below the buy point. A harsher decline that falls outside of these parameters, and you should start to consider cutting your position.|
• Familiarize yourself with IBD’s sell rules. If a stock has risen more than 10% from the buy point, you should sell it before all profits are gone. You never want to let a double-digit gain turn into a loss.|
• Familiarize yourself with IBD’s sell rules. If a stock has risen more than 10% from the buy point, you should sell it before all profits are gone. You never want to let a double-digit gain turn into a loss.|
• In the best-case scenario, a pullback allows the moving averages to catch up to the stock price. Your stock finds support and uses it like a springboard.

3 Likes

Buying $ALKT. I bought the other half of my position today when it was 3% into the buy zone on strong volume. Probably could have got it 1% cheaper if I had looked at 1130 after I got back from yoga and before I took the dog to training. I thought retirement meant you had lots of free time.

In the chart below you can see where I bought originally (too high, too eager?) and then got stopped out where I sold at the red line. Then after support and bounce I got a 50% position (green line) just at the buy point, and then another 50% position at 3% in. (ok, I had to raise a little money for the last 1/6th position, and I had to buy that at 4% into the zone because some joker jacked it up while I was selling VRT).

Lesson Learned: I can get over excited and buy too late and too high like I did the first time with this. I had to sell and buy it back at a higher price than I sold. A lot of gap ups will give you a short down-tend for buying at a lower price. Bill always said that buy at the precise point was critical in avoiding getting shaken out later. His research shows that 40% of breakouts retrace to the buy point.

$VRT: I bought this in my IBD account, but it was not really using an IBD rule. It was in a strong run and the visited the 50dam and had a good bounce so I bought 1/3 position. This is the kind of thing that I should leave to my future SimonSez account.

Thanks for listening, talking out loud helps me learn.

2 Likes

Yea it’s been very volatile today. I like the way you mark up your charts. Very informative.

Andy

@PuddinHead42 I don’t know if you saw this Pete.

Andy

@buynholdisdead Andy, I don’t think I saw this power trend video. I have read a few articles and seen people talk about it, but Mike may have been a key creator and I will watch this weekend. Thanks.

$HOOD is a chart worth watching. Had a great shakeout in the base and is now seeing accumulation.

2 Likes

LOL I bought Hood today at $19.94

Yes Mike was one of the ones who invented it. He was talking about it today on X.

Andy

Some charts to peruse, especially if you have MarketSurge…

○ Some IBD stocks near or in buy zones: AROC, HOOD, AVGO, MPWR, CELH, NVO, ISRG, TOL, PHM, , BROS, PDD (they own TEMU), NFLX

CRWD is down a bit due to Palo Altos earnings report tonight, but it is building a nice base that should be watched. (Mike Webster says it really broke out a few days ago). CrowdStrike (CRWD) has teamed up with Google Cloud, aiming to transform AI-native cybersecurity. CRWD stock is poised to unleash a new breakout as it edges out PANW stock for top billing among cybersecurity stocks. On May 9, CrowdStrike and Alphabet (GOOGL)-owned Google Cloud announced the expansion of their existing strategic partnership. The enhanced collaboration leverages the CrowdStrike Falcon platform with the Google Cloud Security Operations platform.

ATEN: look at chart to see move after gap up (too late to buy) Look how the day after the gap up had a nice little reversal. Was that hinting at the strength to come? NEM, another gap up with a dip and then a take off. Also see SG gap, dip and pop.

VST: has seen a ton of accumulate (see the ants on MarkgeSurge). Today was a little messy. I am keeping it on my watch list to see if it will build a tight flat base, then with all the recent accumulation, the breakout could be very strong.|

2 Likes

I noticed Ants on Celh also.

Andy

2 Likes

IOT has pulled back a little and is giving you a better buy point. IBD says these gentle pullbacks to the pivot point are a good time to pick some up. And IOT’s Fundamentals look good.

Andy

2 Likes

look at the fund accumulation on SMCI. Really impressive.

Andy

This is VKTX. It’s a biotech that is in phase 3 of it’s GLP-1 drug and in phase 1 of it’s GLP-1 pill form drug. It also has a nash drug in the pipeline. This is high risk high reward but Look at the fund accumulation.

Andy

MNDY is a SaaS company. It has been Gaaping up since earnings. It is now at a pivot point. I bought a position today.

Andy

RE: CELH, yes, it looks good. I have that in my Saul-IBD sandbox.
RE: MNDY, also good, bought some on the gap up and some today in my Saul-IBD sandbox
RE: SMCI is a real company that feels like a meme stock. Its near-term performance will be 100% based on NVDA earnings Wed. I cannot buy either before the earnings are out. (As noted on other thread, I sold my NVDA in Saul sandbox and used money to add to CRWD and MNDY today).
RE: IOT. Yes, another good chart with good growth fundamentals. Mostly tracking trucks with GPS, but also has other IOT products, which will grow. I believe they have recurring revenues, which is important. I have this in my Saul-IBD sandbox.

*I am down to a few % cash in my Saul-IBD account and just sold one stock to get to 10% cash in my IBD account. I think there will be good opportunities if NVDA exceeds expectations, if not, cash is even better. AROC is on my hot list.

2 Likes

@buynholdisdead Andy, Investors.com has a separate subscription (that I also have), but it has a lot of free stuff. I know you are aware and reading articles and watching videos. There is a “column” called “The New America”, which highlights smaller up and coming companies that are doing “New” things. It can be found under the Research link.

I try to review it but sometimes forget. Apparently on 5/16 they covered ALKT
Online Banking: Alkami Stock Advances As Firm Turns Profitable | Investor’s Business Daily (investors.com)

2 Likes

MNDY notes. @buynholdisdead I bought this on an IBD breakout in my Saul-IBD sandbox. I post it here to make some general points about IBD trading. One thing they advise is to do a post analysis of all your trades and then determine what is working and what is not. All traders should do this to be better. So I am working hard to do it right, and it is a bit of work. What I do is have a power point file that is created fresh at each new Follow-Through-Day. I track each trade and take notes to help post analysis later. I keep a journal of any adds or sales and my general logic on actions. Then, when there is a market correction and not much trading is going on, I try to go through all my notes and compile a summary analysis. Here is partially what my PPT looks like.

Here is what the notes section of my PPT slide looks like…

Post Analysis:

  • Breakout Strength: strong +84% vol
  • Base Stage: 2
  • Right-Side Strength: very good just before earnings, during and after earnings report.
  • Gap ups or shakeouts in base: earnings was a huge gap up above 50dma. There was some shakeout like action near the bottom
  • Group Rank: 84
  • RS: 86
  • Trend Lines: 21dma just getting above 50dma on breakout day.
  • WON score: 9/9
  • Chaikin Power Guage: Neutral-
  • Long Term Potential: very good, this enterprise SaaS product is the best in class and could spread to a large number of enterprises. Addition of AI features could spur growth.

**Sell Rationale: **
Profit/Loss:

Commentary:

  • 5/21/24: bought this in the Saul account on a strong breakout with +94% volume and about 5.5% price increase. (Sold NVDA before earnings to fund it). 4 days ago, I bought in on the giant earnings gap up above the 50dma. (But that was more of a “this is one of the strong Saul stocks rather than it is going to be an IBD stock”.

Here is a snippet from an IBD checklist I like to use to remind me to look at the base before I buy…


and I note my observations in my bullet list.

1 Like

I sold my TQQQ yesterday and put it into alkt yesterday and Mndy today. I am looking at wing. They just formed a tight and I have wanted this one for awhile.

Andy

1 Like

That looks Great Pete. Very detailed, I like the way you are doing it. I have been writing them down in my journal but not that detailed. I need to start doing that thanks.

Andy

1 Like

I agree with you Pete but SMCI is the leading company in the leading Sector. It could get decimated by NVDA earnings call but I have 7 percent of my portfolio in it now because of its leading position. It is looking better.

Andy

This is one that needs to have an eye on VITL. Look at the RS line, straight up. Just waiting for an entry point. Missed the pivot on the cup.

Andy